Leadership

Digital health company UpHealth has named Dr. Mahesh Inder Veer Singh executive vice president.

Eight physicians joined Becker's to discuss their top priorities through the end of the year. 

Liver disease therapeutics company Ochre Bio has assembled a 10-member scientific strategy board following the close of a $30 million series A funding round. 

Theseus Pharmaceuticals, a biopharmaceutical company focused on developing drugs for cancer patients, has appointed Steven Stein, MD, to its board of directors. 

Six physicians joined Becker's to discuss their secrets to success. 

Austin, Texas chief medical officer Mark Escott, MD, has been named a project leader for the University of Texas Austin Center for Pandemic Decision Science, a team being assembled with a $1 million grant from the National Science Foundation. 

For Christy Bray Ricks, vice president of provider talent at Ardent Health in Nashville, Tenn., intentional touchpoints are the key to maintaining a centralized team. 

Versanis Bio, a company that creates therapeutics used in the treatment of obesity and cardiometabolic diseases, has named Kenneth Attie, MD, chief medical officer and executive vice president.

Sandhya Gardner, MD, a chief medical officer at Burlington, Mass.-based digital healthcare provider HealthEdge, has been promoted from chief medical officer of HealthEdge's software, Wellframe, to chief medical officer of HealthEdge's clinical solutions. 

Biotech company Revance has named David Hollander, MD, as its chief medical officer in charge of clinical development, data science, medical affairs, innovation and regulatory affairs.